Chemotherapy for metastatic and recurrent cervical cancer
about
Palliative interventions for controlling vaginal bleeding in advanced cervical cancerFlavonol and imidazole derivatives block HPV16 E6 activities and reactivate apoptotic pathways in HPV⁺ cellsManagement and Care of Women With Invasive Cervical Cancer: American Society of Clinical Oncology Resource-Stratified Clinical Practice Guideline.Voluntary exercise prevents cisplatin-induced muscle wasting during chemotherapy in miceNew molecular targets against cervical cancer.Patient age, tumor appearance and tumor size are risk factors for early recurrence of cervical cancer.From prospective biobanking to precision medicine: BIO-RAIDs - an EU study protocol in cervical cancerResponse to chemotherapy in patients with recurrent rectal cancer in previously irradiated area.'BRCAness' and its implications for platinum action in gynecologic cancer.Primary debulking surgery for metastatic cervical adenocarcinoma: A case report.Gemcitabine and carboplatin demonstrate synergistic cytotoxicity in cervical cancer cells by inhibiting DNA synthesis and increasing cell apoptosis.High aldehyde dehydrogenase activity identifies cancer stem cells in human cervical cancer.Gene Expression Analysis Reveals the Concurrent Activation of Proapoptotic and Antioxidant-Defensive Mechanisms in Flavokawain B-Treated Cervical Cancer HeLa Cells.Oncologic outcomes of adjuvant chemotherapy alone after radical surgery for stage IB-IIA cervical cancer patients.RNAi‑mediated downregulation of asparaginase‑like protein 1 inhibits growth and promotes apoptosis of human cervical cancer line SiHa.
P2860
Q24188092-E1B4F4C3-A4F0-48A6-B762-77B26A9DAB31Q28817517-8F71D64C-87E7-4777-9110-CF09F9B32D56Q33859732-7DE949C1-B951-455D-BEAE-220DB15A2FCAQ34277951-AF5639C7-C25B-4980-925B-426075FA5FBBQ34700859-301C91F4-0B65-4C1D-95CC-D281FFAEB15CQ35180066-4B85777D-CE7D-461F-BE9D-949D2397DE80Q35831356-D1E58A1B-F572-4CCA-A9B9-A1306D429845Q35881902-512743EF-A216-48CB-B2CD-6B259390AD6DQ36380704-8CC53B59-0383-426E-AFB9-F4E19AFDCC8EQ36397805-BD7C647C-DBE4-4B7C-933B-2E5C0ED8EA5FQ37360356-D38110ED-EE28-46CB-8155-6A485C64CE75Q37589153-CA91A80C-6117-4BA5-B1E9-F1B95D15B5F4Q46511172-B300625E-D9D2-4778-93A1-5499887D8EC8Q47141305-C11EE3E7-E22D-4DD1-B988-48CB92833AAFQ54978952-A1F5F4EF-AB2E-4937-91F6-CB80AC05F24B
P2860
Chemotherapy for metastatic and recurrent cervical cancer
description
2012 nî lūn-bûn
@nan
2012 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Chemotherapy for metastatic and recurrent cervical cancer
@ast
Chemotherapy for metastatic and recurrent cervical cancer
@en
Chemotherapy for metastatic and recurrent cervical cancer
@en-gb
Chemotherapy for metastatic and recurrent cervical cancer
@nl
type
label
Chemotherapy for metastatic and recurrent cervical cancer
@ast
Chemotherapy for metastatic and recurrent cervical cancer
@en
Chemotherapy for metastatic and recurrent cervical cancer
@en-gb
Chemotherapy for metastatic and recurrent cervical cancer
@nl
prefLabel
Chemotherapy for metastatic and recurrent cervical cancer
@ast
Chemotherapy for metastatic and recurrent cervical cancer
@en
Chemotherapy for metastatic and recurrent cervical cancer
@en-gb
Chemotherapy for metastatic and recurrent cervical cancer
@nl
P2093
P2860
P1476
Chemotherapy for metastatic and recurrent cervical cancer
@en
P2093
Chris Williams
Jennifer L Forrest
Kate Scatchard
Maxine Flubacher
Paul Cornes
P2860
P304
P356
10.1002/14651858.CD006469.PUB2
P577
2012-10-17T00:00:00Z